Linked Life Data

15188065

Source:http://linkedlifedata.com/resource/pubmed/id/15188065

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
5
pubmed:dateCreated
2004-6-9
pubmed:abstractText
The number of Staphylococcus aureus (S. aureus) community and nosocomial acquired infections have increased in the last twenty years. Between 1990 and 1992, this pathogen has become the most frequent source of nosocomial infections 1,2. On the other hand, as result of antibiotherapy selection pressure, we observe a dramatic increase in the methicillin-resistant S. aureus (MRSA) infections 3,4. With the recent emergence of multiresistant strains, including glycopeptides resistance, the treatment of these infections became still more difficult 2,4-6. It's important to prevent resistant strains emergence. To prevent further emergence of resistant strains, the use of antibiotherapy must be optimised, laboratory methods for the detection of resistant pathogens must be enhanced and strict precautions should be taken following of the infection or colonization of patients 6-10. In this paper, we review anti-staphylococci history evolution and point out the present recommendations for the treatment and prevention of Staphylococcus aureus infections and colonization.
pubmed:language
por
pubmed:journal
pubmed:citationSubset
IM
pubmed:status
MEDLINE
pubmed:issn
0873-2159
pubmed:author
pubmed:issnType
Print
pubmed:volume
9
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
395-409
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed:articleTitle
[Treatment and prevention of Staphylococcus aureus].
pubmed:affiliation
Interna Complementar de Nefrologia, Serviço de Medicina Interna B do Hospital de São João.
pubmed:publicationType
Journal Article, English Abstract, Review